Die Wirkung von progressiven Entspannungsübungen und geplanter Aufklärung auf Wechseljahresbeschwerden, empfundenen Stress und Angst bei Frauen in den Wechseljahren
Die Wirkung von progressiven Entspannungsübungen und geplanter Aufklärung auf Wechseljahrsbeschwerden, wahrgenommenen Stress und Angst bei Frauen in den Wechseljahren
The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxiety in Menopausal Women
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
The study will be conducted with women who are in the menopausal period. Data will be collected using the Personal Information Form, Menopause Symptoms Assessment Scale, Perceived Stress Scale and Beck Anxiety Scale.
Study; It will be divided into three groups: progressive relaxation exercise group, planned training group and control group. A total of 144 participants, 48 for each group, were planned to be included in the sample.
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Merkez
-
Sivas, Merkez, Türkei (türkiye), 00058
- Sivas Cumhuriyet University
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Not having communication and perception problems
- Being in menopause
- Not having a mental illness diagnosis
- Voluntary participation in the study
Exclusion Criteria:
- Having communication and perception problems
- Not being in menopause
- Not having a mental illness diagnosis
- Not being a volunteer to participate in the study
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Experimental: progressive relaxation exercise
Progressive relaxation exercises combine deep breathing with the contraction and relaxation of muscle groups such as the hands, arms, upper arms, feet, lower legs and calves, hips, abdomen and lower back, chest, face, shoulders and back, neck, jaw, lips, eyes, and forehead. After taking a deep breath, the muscles are tensed, this tension is maintained for 5-10 seconds, and then the muscles are relaxed (10-20 seconds). When a muscle is tense, the deeper the tension, the deeper the relaxation will be when it is released. During the exercise, the individual is asked to continue breathing in slowly and deeply through the nose and exhaling through the mouth. |
Progressive relaxation exercises begin with breathing exercises and continue with muscle stretching and relaxation exercises, lasting an average of 30 minutes. |
|
Experimental: planned education
The topics covered in the educational content include: What menopause is, causes of menopause, factors affecting the onset of menopause, complaints during menopause, general symptoms of menopause, nutrition during menopause, sleep during menopause, emotional problems during menopause, and coping strategies. |
The training group will receive pre-planned training in accordance with the literature, delivered as group training in line with adult learning principles. |
|
Kein Eingriff: control group
The control group will not receive any intervention; only the Perceived Stress Scale, Menopause Symptom Assessment Scale, and Beck Anxiety Scale will be administered as pre-tests and post-tests. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Perceived Stress Scale
Zeitfenster: Beginning
|
The scale consists of 10 items and is evaluated based on a total score. The scale is scored on a scale of 1-5. The total score ranges from 10 to 50, and an increase in the score indicates an increase in perceived stress level. The scale is assessed before any training or relaxation exercises during the initial encounter with women. |
Beginning
|
|
Beck Anxiety Scale
Zeitfenster: Beginning
|
The scale ranges from a minimum of 0 to a maximum of 63 points. However, based on the scores obtained on the scale, patients' anxiety levels are classified as follows: 0-7 points is low, 8-15 points is mild, 16-25 points is moderate, and 26-63 points is high anxiety. A high score indicates that the individual is experiencing a high level of anxiety.The scale is assessed before any training or relaxation exercises during the initial encounter with women. |
Beginning
|
|
Menopause Symptom Assessment Scale
Zeitfenster: Beginning
|
The scale consists of 11 items and 3 subscales. An increase in the total score obtained from the scale indicates an increase in the severity of complaints and, consequently, a negative impact on quality of life. The lowest possible score on the entire scale is 0, and the highest is 44.The scale is assessed before any training or relaxation exercises during the initial encounter with women. |
Beginning
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Perceived Stress Scale
Zeitfenster: One month after relaxation exercises and planned training practices
|
The scale consists of 10 items and is evaluated based on a total score. The scale is scored on a scale of 1-5. The total score ranges from 10 to 50, and an increase in the score indicates an increase in perceived stress level. The scale is administered to the women again one month after the planned training and relaxation exercises are implemented. |
One month after relaxation exercises and planned training practices
|
|
Beck Anxiety Scale
Zeitfenster: One month after relaxation exercises and planned training practices
|
Description: The scale ranges from a minimum of 0 to a maximum of 63 points. However, based on the scores obtained on the scale, patients' anxiety levels are classified as follows: 0-7 points is low, 8-15 points is mild, 16-25 points is moderate, and 26-63 points is high anxiety. A high score indicates that the individual is experiencing a high level of anxiety.The scale is administered to the women again one month after the planned training and relaxation exercises are implemented. |
One month after relaxation exercises and planned training practices
|
|
Menopause Symptom Assessment Scale
Zeitfenster: One month after relaxation exercises and planned training practices
|
Description: The scale consists of 11 items and 3 subscales. An increase in the total score obtained from the scale indicates an increase in the severity of complaints and, consequently, a negative impact on quality of life. The lowest possible score on the entire scale is 0, and the highest is 44.The scale is administered to the women again one month after the planned training and relaxation exercises are implemented. |
One month after relaxation exercises and planned training practices
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Hauptermittler: Sukran Ertekin Pinar, Cumhuriyet University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- TR SİVAS 08
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .